# Topical 0.01% Atropine for the Control of Fast Progressing Myopia

> **NCT04173780** · PHASE2,PHASE3 · TERMINATED · sponsor: **University Hospital, Strasbourg, France** · enrollment: 60 (actual)

## Conditions studied

- Myopia Progressing
- Childhood

## Interventions

- **DRUG:** Atropine 0.01%
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04173780
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-02-12
- **Primary completion:** 2024-05-15
- **Final completion:** 2024-06-03
- **Target enrollment:** 60 (ACTUAL)
- **Why stopped:** recruitment difficulties
- **Last updated:** 2024-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04173780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04173780, "Topical 0.01% Atropine for the Control of Fast Progressing Myopia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04173780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*